Skip to main content

What the FDA labels say about taking them together

Bromocriptine and cabergoline

Cabergoline's FDA label of June 30, 2026 names bromocriptine in its warnings and precautions section; the bromocriptine labels PlainMeds reads (2) do not name cabergoline.

Check it at the source: the bromocriptine FDA label on DailyMed (effective July 27, 2026, ANI Pharmaceuticals, Inc.); the cabergoline FDA label on DailyMed (effective June 30, 2026, Mylan Pharmaceuticals Inc.).

What does the bromocriptine label say about cabergoline?

Bromocriptine's label (effective July 27, 2026) and its 1 other brand-application label do not name cabergoline in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Bromocriptine Mesylate), ANI Pharmaceuticals, Inc., effective July 27, 2026 (SPL set 17f3a343-1782-4799-95ba-31dfe93be2cf), via openFDA; the full label on DailyMed

What does the cabergoline label say about bromocriptine?

Cabergoline label, warnings and precautions

Use of bromocriptine, another dopamine agonist for this unapproved use has been associated with cases of hypertension, stroke, myocardial infarction, seizures, and death.

Source: FDA drug label (Cabergoline), NDA020664 (Pfizer), as published by Mylan Pharmaceuticals Inc., effective June 30, 2026 (SPL set e497366b-a124-4d7f-bd45-a883c392d4bb), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

6Bromocriptine generic labelers
8Cabergoline generic labelers
BromocriptineCabergoline
Labeled forParkinson's disease, Type 2 diabetesn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$1.61 per tablet 2.5 mg tablet$1.30 per tablet 0.5 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?